Overview of the Clinical Pharmacology of Ertugliflozin, a Novel Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor.
Clin Pharmacokinet
; 59(8): 949-965, 2020 08.
Article
in En
| MEDLINE
| ID: mdl-32337660
Full text:
1
Database:
MEDLINE
Main subject:
Bridged Bicyclo Compounds, Heterocyclic
/
Diabetes Mellitus, Type 2
/
Sodium-Glucose Transporter 2 Inhibitors
/
Hypoglycemic Agents
Limits:
Adult
/
Humans
Language:
En
Journal:
Clin Pharmacokinet
Year:
2020
Type:
Article
Affiliation country:
United States